TUMOR-CONTROL IN LONG-TERM SURVIVORS FOLLOWING SUPERFICIAL HYPERTHERMIA

被引:61
作者
MYERSON, RJ [1 ]
PEREZ, CA [1 ]
EMAMI, B [1 ]
STRAUBE, W [1 ]
KUSKE, RR [1 ]
LEYBOVICH, L [1 ]
VONGERICHTEN, D [1 ]
机构
[1] WASHINGTON UNIV,SCH MED,EDWARD MALLINCKRODT INST RADIOL,CTR RADIAT ONCOL,ST LOUIS,MO 63110
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1990年 / 18卷 / 05期
关键词
Hyperthermia physics; Microwave hyperthermia; Superficial hyperthermia;
D O I
10.1016/0360-3016(90)90448-S
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sixty tumors with a minimum of 1-year follow-up were treated with radiation and superficial microwave hyperthermia (915 MHz). The overall local control rate was 50% ( 30 60). The most important factor in outcome was appropriateness of the hyperthermia applicator. Tumors covered by at least the 25% iso-SAR contour achieved 65% local control versus 21% local control with less than 25% SAR coverage (p < 0.01). Several measures of adequate minimum monitored tumor temperature and duration were considered. The measure best correlated with outcome was best single session time at or above 43°C (t43). If each monitored tumor catheter achieved t43 ≥ 30 minutes in at least one session, then tumor control was significantly (p < 0.01) improved (63% with Min t43 ≥ 30 versus 25% with Min t43 < 30). Although there was considerable overlap between tumors with SAR ≥ 25% and those achieving Min t43 ≥ 30, a statistically significant (p = 0.02) difference could be demonstrated between the group meeting both the SAR and the minimum tumor time/duration standards as opposed to those meeting only one standard. The actuarial local progression-free survival for tumors most likely to have had adequate hyperthermia (defined as SAR ≥ 25% and Min t43 > 30) and all other tumors did not begin to separate significantly until 8 to 12 months after treatment. Implications for future randomized studies are discussed. © 1990.
引用
收藏
页码:1123 / 1129
页数:7
相关论文
共 19 条
[11]  
OVERGAARD J, 1984, HYPERTHERMIC ONCOLOG, V1, P383
[12]  
PEREZ C A, 1986, International Journal of Hyperthermia, V2, P179, DOI 10.3109/02656738609012393
[13]   QUALITY ASSURANCE PROBLEMS IN CLINICAL HYPERTHERMIA AND THEIR IMPACT ON THERAPEUTIC OUTCOME - A REPORT BY THE RADIATION-THERAPY-ONCOLOGY-GROUP [J].
PEREZ, CA ;
GILLESPIE, B ;
PAJAK, T ;
HORNBACK, NB ;
EMAMI, B ;
RUBIN, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (03) :551-558
[14]  
PEREZ CA, 1985, ENDOCURIETHERAPY HYP, V1, P265
[15]  
PEREZ CA, 1984, HYPERTHERMIC ONCOLOG, V1, P181
[16]   THERMAL DOSE DETERMINATION IN CANCER-THERAPY [J].
SAPARETO, SA ;
DEWEY, WC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (06) :787-800
[17]  
STRAUBE W, IN PRESS INT J HYPER
[18]   IMPORTANT PROGNOSTIC FACTORS INFLUENCING OUTCOME OF COMBINED RADIATION AND HYPERTHERMIA [J].
VALDAGNI, R ;
LIU, FF ;
KAPP, DS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 15 (04) :959-972
[19]   RESPONSE OF HUMAN-TUMOR BLOOD-FLOW TO LOCAL HYPERTHERMIA [J].
WATERMAN, FM ;
NERLINGER, RE ;
MOYLAN, DJ ;
LEEPER, DB .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1987, 13 (01) :75-82